Elanco CEO receives deferred stock unit grant

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc President and CEO Jeffrey N. Simmons received a grant of 123.8795 deferred stock units on Company common stock. These units were valued at $22.82 per unit on the grant date and increase his directly held deferred stock unit balance to 23,919.1498 units.

Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent. The units will settle in cash or shares following Simmons’ termination of employment or in a specified future year under the Company’s Executive Deferral and Stock Match Plan, making this a routine, compensation-related award rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 123.8795 shares

Grant/Award 1 txn

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	123.8795	$22.82	$3K

Holdings After Transaction: Deferred Stock Units — 23,919.1498 contracts (Direct)

Footnotes (2)

1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 123.8795 units Grant date unit value: $22.82 per unit Deferred stock units held after grant: 23,919.1498 units +1 more

4 metrics

Deferred stock units granted 123.8795 units Grant to CEO Jeffrey Simmons on April 3, 2026

Grant date unit value $22.82 per unit Reference price for deferred stock unit award

Deferred stock units held after grant 23,919.1498 units Total direct deferred stock unit balance following transaction

Conversion price $0.00 Conversion or exercise price for the deferred stock units

Key Terms

Deferred Stock Units, Executive Deferral and Stock Match Plan, Form 4

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Executive Deferral and Stock Match Plan financial

"Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elanco (ELAN) CEO Jeffrey Simmons report in this Form 4 filing?

Jeffrey Simmons reported receiving 123.8795 deferred stock units as a compensation-related grant. These units are tied to Elanco common stock and increase his deferred stock unit holdings to 23,919.1498 units, with settlement occurring in cash or shares at a future time.

Are the Elanco (ELAN) deferred stock units a stock purchase by the CEO?

No, the deferred stock units are a grant, not an open-market stock purchase. They are part of compensation, representing a right to receive Elanco common stock or cash later, rather than a discretionary buy or sell in the market.

How many deferred stock units did the Elanco (ELAN) CEO receive and at what value?

Jeffrey Simmons received 123.8795 deferred stock units, valued at $22.82 per unit on the grant date. These units mirror Elanco common stock value and will convert into shares or cash according to plan terms at settlement.

When will Jeffrey Simmons’ Elanco (ELAN) deferred stock units settle?

The deferred stock units will settle in cash or Elanco common shares after Simmons’ termination of employment or during a specified future year. Settlement timing follows the Company’s Executive Deferral and Stock Match Plan rules described in the filing’s footnotes.

How many deferred stock units in Elanco (ELAN) does the CEO hold after this transaction?

After this grant, Jeffrey Simmons directly holds 23,919.1498 deferred stock units. Each unit represents the right to receive one Elanco common share or the cash equivalent upon future settlement, according to the Company’s deferral plan provisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/07/2026 - 05:18 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS INDIANA 46221

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	04/03/2026		A		123.8795		(2)	(2)	Common Stock	123.8795	$22.82	23,919.1498	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)